International cancer seminars: A focus on esophageal squamous cell carcinoma

Annals of Oncology

Volumn 28, Issue 9, 2017, Pages 2086-2093

  Murphy, G ^a   McCormack, V ^b   Abedi Ardekani, B ^b   Arnold, M ^b   Camargo, M C ^a   Dar, N A ^c   Dawsey, S M ^a   Etemadi, A ^a   Fitzgerald, R C ^d   Fleischer, D E ^e   Freedman, N D ^a   Goldstein, A M ^a   Gopa, S ^a   Hashemian, M ^a,g   Hu, N ^a   Hyland, P L ^a   Kaimila, B ^f   Kamangar, F ^h   Malekzadeh, R ^g   Mathew, C G ^i,j   Menya, D ^k   Mulima, G ^f   M Mwachiro, M ^l   Mwasamwaja, A ^m   Pritchett, N ^a   Qiao, Y L ⁿ   Ribeiro Pinto, L F ^o   Ricciardone, M ^a   Schuz J ^b   Sitas, F ^p,q   Taylor, P R ^a   Van Loon, K ^r   Wang, S M ^a,n   Wei, W Q ⁿ   Wild, C P ^b   Wu, C ⁿ   Abnet, C C ^a   Chanock, Stephen J ^a   Brennan, P ^b   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF KASHMIR   (India)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h MORGAN STATE UNIVERSITY   (United States)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^k MOI UNIVERSITY   (Kenya)

^l Tenwek Hospital   (Kenya)

^m KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

ⁿ CANCER HOSPITAL   (China)

^o INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^p UNIVERSITY OF SYDNEY   (Australia)

^q UNIVERSITY OF NEW SOUTH WALES   (Australia)

^r UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Clinical research; Early detection; Epidemiology; Esophageal squamous cell carcinoma (ESCC); Genomics

Indexed keywords

CANCER INCIDENCE; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; EARLY DIAGNOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENETIC ASSOCIATION; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; EARLY CANCER DIAGNOSIS; ESOPHAGUS TUMOR; GENETICS; INTERNATIONAL COOPERATION; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; HUMANS; INTERNATIONALITY; RISK FACTORS;

EID: 85028700785     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdx279     Document Type: Review

References (111)

1. Scelo G, Hofmann JN, Banks RE et al. International cancer seminars: a focus on kidney cancer. Ann Oncol 2016; 27(8): 1382-1385
2. Ferlay JSI, Ervik M, Dikshit R et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013
3. Arnold M, Soerjomataram I, Ferlay J et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64(3): 381-387
4. Forman D, Bray F, Brewster DH et al. Lyon, France: IARC Scientific Publication No. 164
5. Tuyns AJ. Oesophageal cancer in non-smoking drinkers and in nondrinking smokers. Int J Cancer 1983; 32(4): 443-444
6. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95(18): 1404-1413
7. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105(Suppl 2): S77-S81
8. Olsen JH, Andersen A, Dreyer L et al. Summary of avoidable cancers in the Nordic countries. APMIS Suppl 1997; 76: 141-146
9. International Agency for Research on Cancer (IARC) (2007) Attributable Causes of Cancer in France in the Year 2000. IARC Working Group Reports 3. IARC: Lyon
10. Tran GD, Sun XD, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113(3): 456-463
11. Liu BQ, Peto R, Chen ZM et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. Br Med J 1998; 317(7170): 1411-1422
12. Gu D, Kelly TN, Wu X et al. Mortality attributable to smoking in China. N Engl J Med 2009; 360(2): 150-159
13. Wang JB, Fan JH, Liang H et al. Attributable causes of esophageal cancer incidence and mortality in China. PLoS ONE 2012; 7(8): e42281
14. Kamangar F, Chow WH, Abnet CC et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009; 38(1): 27-57, vii
15. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66(1): 7-30
16. Zeng H, Zheng R, Guo Y et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer 2015; 136(8): 1921-1930
17. De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15(1): 23-34
18. Dawsey SP, Tonui S, Parker RK et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS ONE 2010; 5(11): e14080
19. White RE, Parker RK, Fitzwater JW et al. Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement. Lancet Oncol 2009; 10(3): 240-246
20. Launoy G, Milan C, Day NE et al. Oesophageal cancer in France: potential importance of hot alcoholic drinks. Int J Cancer 1997; 71(6): 917-923
21. McCormack VA, Menya D, Munishi MO et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: a review of setting-specific exposures to known and putative risk factors. Int J Cancer 2017 Jan 15; 140(2): 259-271
22. IARC. Acetaldehyde. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer (IARC) 1999; 319-335
23. IARC. A Review of Human Carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer (IARC) 2011
24. Gao Y, Hu N, Han XY et al. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol 2011; 35(6): e91-e99
25. Islami F, Pourshams A, Nasrollahzadeh D et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. Br Med J 2009; 338: b929
26. Lubin JH, De Stefani E, Abnet CC et al. Mate drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies. Cancer Epidemiol Biomarkers Prev 2013; 23(1): 107-116
27. Munishi MO, Hanisch R, Mapunda O et al. Africa's oesophageal cancer corridor: do hot beverages contribute? Cancer Causes Control 2015; 26(10): 1477-1486
28. Loomis D, Guyton KZ, Grosse Y et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol 2016; 17(7): 877-878
29. Lubin JH, De Stefani E, Abnet CC et al. Mate drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies. Cancer Epidemiol Biomarkers Prev 2014; 23(1): 107-116
30. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Oesophageal Cancer 2016
31. Li WQ, Park Y, Wu JW et al. Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin Gastroenterol Hepatol 2013; 11(9): 1130-1136 e2
32. Sewram V, Sitas F, O'Connell D et al. Diet and esophageal cancer risk in the Eastern Cape Province of South Africa. Nutr Cancer 2014; 66(5): 791-799
33. Schaafsma T, Wakefield J, Hanisch R et al. Africa's oesophageal cancer Corridor: geographic variations in incidence correlate with certain micronutrient deficiencies. PLoS ONE 2015; 10(10): e0140107
34. Qiao YL, Dawsey SM, Kamangar F et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 2009; 101(7): 507-518
35. Limburg PJ, Wei W, Ahnen DJ et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 2005; 129(3): 863-873
36. Mark SD, Qiao YL, Dawsey SM et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000; 92(21): 1753-1763
37. Roth MJ, Qiao Y-L, Rothman N et al. High urine 1-hydroxypyrene glucuronide concentrations in Linxian, China, an area of high risk for squamous oesophageal cancer. Biomarkers 2001; 6(5): 381-386
38. Kamangar F, Strickland PT, Pourshams A et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 2005; 25(1B): 425-428
39. Fagundes RB, Abnet CC, Strickland PT et al. Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer 2006; 6: 139
40. Abedi-Ardekani B, Kamangar F, Hewitt SM et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 2010; 59(9): 1178-1183
41. Roth MJ, Strickland KL, Wang GQ et al. High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer 1998; 34(5): 757-758
42. Golozar A, Fagundes RB, Etemadi A et al. Significant variation in the concentration of carcinogenic polycyclic aromatic hydrocarbons in yerba mate samples by brand, batch, and processing method. Environ Sci Technol 2012; 46(24): 13488-13493
43. Kamangar F, Schantz MM, Abnet CC et al. High levels of carcinogenic polycyclic aromatic hydrocarbons in mate drinks. Cancer Epidemiol Biomarkers Prev 2008; 17(5): 1262-1268
44. Koshiol J, Wei WQ, Kreimer AR et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010; 127(1): 93-100
45. Sitas F, Egger S, Urban MI et al. InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012; 104(2): 147-158
46. Halec G, Schmitt M, Egger S et al. Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis. Int J Cancer 2016; 139(1): 85-98
47. Herbster S, Ferraro CT, KoffNK et al. HPV infection in Brazilian patients with esophageal squamous cell carcinoma: interpopulational differences, lack of correlation with surrogate markers and clinicopathological parameters. Cancer Lett 2012; 326(1): 52-58
48. Liu W, Snell JM, Jeck WR et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight 2016; 1(16): e88755
49. Abnet CC, Qiao YL, Mark SD et al. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control 2001; 12(9): 847-854
50. Abnet CC, Qiao YL, Dawsey SM et al. Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol 2005; 34(2): 467-474
51. Abnet CC, Kamangar F, Islami F et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17(11): 3062-3068
52. Dar NA, Islami F, Bhat GA et al. Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer 2013; 109(5): 1367-1372
53. Guha N, Boffetta P, Wunsch Filho V et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007; 166(10): 1159-1173
54. Plowright W. Malignant neoplasia of the oesophagus and rumen of cattle in Kenya. J Comp Pathol 1955; 65(2): 108-114
55. Nasrollahzadeh D, Ye W, Shakeri R et al. Contact with ruminants is associated with esophageal squamous cell carcinoma risk. Int J Cancer 2015; 136(6): 1468-1474
56. Dar NA, Islami F, Bhat GA et al. Contact with animals and risk of oesophageal squamous cell carcinoma: outcome of a case-control study from Kashmir, a high-risk region. Occup Environ Med 2014; 71(3): 208-214
57. Yu G, Gail MH, Shi J et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev 2014; 23(5): 735-741
58. Nasrollahzadeh D, Malekzadeh R, Ploner A et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep 2015; 5: 8820
59. Pourshams A, Khademi H, Malekshah AF et al. Cohort Profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2010; 39(1): 52-59
60. Kamangar F, Shakeri R, Malekzadeh R et al. Opium use: an emerging risk factor for cancer? Lancet Oncol 2014; 15(2): e69-e77
61. Islami F, Ren JS, Taylor PR et al. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer 2009; 101(9): 1641-1647
62. Dar NA, Bhat GA, Shah IA et al. Salt tea consumption and esophageal cancer: a possible role of alkaline beverages in esophageal carcinogenesis. Int J Cancer 2015; 136(6): E704-E710
63. Nieminen MT, Novak-Frazer L, Collins R et al. Alcohol and acetaldehyde in African fermented milk mursik-a possible etiologic factor for high incidence of esophageal cancer in western Kenya. Cancer Epidemiol Biomarkers Prev 2013; 22(1): 69-75
64. Gao Y, Hu N, Han X et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 2009; 9: 269
65. Akbari MR, Malekzadeh R, Nasrollahzadeh D et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer 2006; 119(5): 1047-1051
66. Hu N, Dawsey SM, Wu M et al. Family history of oesophageal cancer in Shanxi Province, China. Eur J Cancer 1991; 27(10): 1336
67. Li JY, Ershow AG, Chen ZJ et al. A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int J Cancer 1989; 43(5): 755-761
68. Sampson JN, Wheeler WA, Yeager M et al. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. J Natl Cancer Inst 2015; 107(12): djv279
69. Blaydon DC, Etheridge SL, Risk JM et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet 2012; 90(2): 340-346
70. Brooks PJ, Enoch MA, Goldman D et al. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 2009; 6(3): e50
71. Hashibe M, McKay JD, Curado MP et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet 2008; 40(6): 707-709
72. Akbari MR, Malekzadeh R, Nasrollahzadeh D et al. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene 2008; 27(9): 1290-1296
73. Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN et al. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. J Natl Cancer Inst 2015; 107(5)
74. Wang LD, Zhou FY, Li XM et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1. Nat Genet 2010; 42(9): 759-763
75. Abnet CC, Freedman ND, Hu N et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42(9): 764-767
76. McKay JD, Truong T, Gaborieau V et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 2011; 7(3): e1001333
77. Wu C, Wang Z, Song X et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet 2014; 46(9): 1001-1006
78. Bye H, Prescott NJ, Lewis CM et al. Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population. Carcinogenesis 2012; 33(11): 2155-2161
79. Abedi-Ardekani B, Hainaut P. Cancers of the upper gastro-intestinal tract: a review of somatic mutation distributions. Arch Iran Med 2014; 17(4): 286-292
80. Bouaoun LSD, Ardin M, Hollstein M et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat 2016; 37: 865-876
81. Gamieldien W, Victor TC, Mugwanya D et al. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa. Int J Cancer 1998; 78(5): 544-549
82. Tamura G, Maesawa C, Suzuki Y et al. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 1992; 83(6): 559-562
83. Putz A, Hartmann AA, Fontes PR et al. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int J Cancer 2002; 98(1): 99-105
84. Rossini A, de Almeida Simao T, Marques CB et al. TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil. Mutat Res 2010; 696(1): 10-15
85. Cao W, Wu W, Yan M et al. Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma. Oncogenesis 2015; 4: e175
86. Hu N, Kadota M, Liu H et al. Genomic landscape of somatic alterations in esophageal squamous cell carcinoma and gastric cancer. Cancer Res 2016; 76(7): 1714-1723
87. Zhang L, Zhou Y, Cheng C et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet 2015; 96(4): 597-611
88. Lin DC, Hao JJ, Nagata Y et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet 2014; 46(5): 467-473
89. Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency et al. Integrated genomic characterization of oesophageal carcinoma. Nature 2017; 541(7636): 169-175
90. Sawada G, Niida A, Uchi R et al. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology 2016; 150(5): 1171-1182
91. Qin HD, Liao XY, Chen YB et al. Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis. Am J Hum Genet 2016; 98(4): 709-727
92. Cheng C, Zhou Y, Li H et al. Whole-genome sequencing reveals diverse models of structural variations in esophageal squamous cell carcinoma. Am J Hum Genet 2016; 98(2): 256-274
93. Ma K, Cao B, Guo M. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clin Epigenetics 2016; 8: 43
94. Lima SC, Hernandez-Vargas H, Simao T et al. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Epigenetics 2011; 6(10): 1217-1227
95. Li X, Zhou F, Jiang C et al. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis. PLoS One 2014; 9(7): e103162
96. Chen C, Peng H, Huang X et al. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma. Oncotarget 2016; 7(4): 4507-4521
97. Song Y, Li L, Ou Y et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014; 509(7498): 91-95
98. Bignell GR, Greenman CD, Davies H et al. Signatures of mutation and selection in the cancer genome. Nature 2010; 463(7283): 893-898
99. Wei WQ, Chen ZF, He YT et al. Long-term follow-up of a community assignment, one-time endoscopic screening study of esophageal cancer in China. J Clin Oncol 2015; 33(17): 1951-1957
100. Etemadi A, Abnet CC, Golozar A et al. Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med 2012; 15(1): 18-21
101. Roth MJ, Liu SF, Dawsey SM et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 1997; 80(11): 2047-2059
102. Pan QJ, Roth MJ, Guo HQ et al. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China. Acta Cytol 2008; 52(1): 14-23
103. Ross-Innes CS, Debiram-Beecham I, O'Donovan M et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multicenter case-control study. PLoS Med 2015; 12(1): e1001780
104. Iyer P, Johnson ML, Lansing R et al. Discovery, validation and feasibility testing of highly discriminant DNA methylation markers for detection of Barrett's esophagus using a capsule sponge device. Gastroenterology 2016; 150(4 (S1)): S66-S67
105. Wei WQ, Abnet CC, Qiao YL et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 2004; 79(1): 80-85
106. Islami F, Kamangar F, Aghcheli K et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 2004; 90(7): 1402-1406
107. Pourshams A, Saadatian-Elahi M, Nouraie M et al. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer 2005; 92(1): 176-181
108. Nasrollahzadeh D, Kamangar F, Aghcheli K et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008; 98(11): 1857-1863
109. Mwachiro MM, Burgert SL, Lando J et al. Esophageal squamous dysplasia is common in asymptomatic Kenyans: a prospective, communitybased, cross-sectional study. Am J Gastroenterol 2016; 111(4): 500-507
110. White RE, Chepkwony R, Mwachiro M et al. Randomized trial of small-diameter versus large-diameter esophageal stents for palliation of malignant esophageal obstruction. J Clin Gastroenterol 2015; 49(8): 660-665
111. Cheng ML, Zhang L, Borok M et al. The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot? Cancer Epidemiol 2015; 39(2): 143-149